Literature DB >> 27343709

Management of dyskinesia in anti-NMDAR encephalitis with tramadol.

Ali Seifi1, Deanna L Kitchen2.   

Abstract

Entities:  

Keywords:  Anti-NMDAR encephalitis; Autoimmune encephalitis; Dyskinesia; Neuro critical care

Mesh：

Substances：

Year:  2016        PMID： 27343709     DOI： 10.1016/j.clineuro.2016.06.003

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN： 0303-8467            Impact factor:   1.876


× No keyword cloud information.
  4 in total

Review 1.  Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review.

Authors:  Marco Vabanesi; Serena Marita Lazzarin; Giordano Cecchetti; Raffaella Fazio; Giovanna Franca Fanelli; Maria Antonietta Volonté; Angela Genchi; Antonino Giordano; Vittorio Martinelli; Sergio Colombo; Paolo Beccaria; Milena Mucci; Jacopo Peccatori; Massimo Filippi; Fabio Minicucci
Journal:  J Neurol       Date:  2020-06-13       Impact factor: 4.849

Review 2.  Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU.

Authors:  Farwa Ali; Eelco F Wijdicks
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.532

3.  Management of Refractory Orofacial Dyskinesia Caused by Anti-N-methyl-d-aspartate Receptor Encephalitis Using Botulinum Toxin.

Authors:  Feixia Zheng; Xiuyun Ye; Xulai Shi; Neha Devi Poonit; Zhongdong Lin
Journal:  Front Neurol       Date:  2018-02-22       Impact factor: 4.003

4.  Case report: Anti-NMDA receptor encephalitis manifesting as rapid weight loss and abnormal movement disorders with alternating unilateral ptosis and contralateral limb tremor.

Authors:  Yue Han; Sizhu Gong; Yafei Wan; Xiyao Fu; Enling He; Min Liu; Fang Deng
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.